Qingdao Vland Biotech INC
SSE:603739
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Qingdao Vland Biotech INC
Total Equity
Qingdao Vland Biotech INC
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Qingdao Vland Biotech INC
SSE:603739
|
Total Equity
¥1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Total Equity
¥24.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Equity
¥19.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Total Equity
¥3.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Total Equity
¥9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Total Equity
¥2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Qingdao Vland Biotech INC
Glance View
Qingdao Vland Biotech Co., Ltd. manufactures biotech products. The company is headquartered in Qingdao, Shandong and currently employs 1,534 full-time employees. The company went IPO on 2019-01-16. The firm's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The firm's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The firm mainly distributes its products in China and overseas markets.
See Also
What is Qingdao Vland Biotech INC's Total Equity?
Total Equity
1.8B
CNY
Based on the financial report for Sep 30, 2025, Qingdao Vland Biotech INC's Total Equity amounts to 1.8B CNY.
What is Qingdao Vland Biotech INC's Total Equity growth rate?
Total Equity CAGR 5Y
12%
Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Qingdao Vland Biotech INC have been 3% over the past three years , 12% over the past five years .
